| Jacob Adal, | |
|
16654 Soledad Canyon Rd, Suite 204, Canyon Country, CA 91387-3217 | |
| (661) 270-6644 | |
| Not Available |
| Full Name | Jacob Adal |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 16654 Soledad Canyon Rd, Canyon Country, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801117072 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Jacob Adal, 16654 Soledad Canyon Rd Ste 204, Canyon Country, CA 91387-3217 Ph: (661) 270-6644 | Jacob Adal, 16654 Soledad Canyon Rd, Suite 204, Canyon Country, CA 91387-3217 Ph: (661) 270-6644 |
News Archive
In the past decade, scientists have made significant progress building the critical knowledge and infrastructure needed to identify and develop novel tuberculosis (TB) vaccine candidates and move the most promising ones into human clinical trials. The results of those trials, coupled with advances from other TB studies, have paved the way for the next 10 years of research on TB vaccines, a critical component of TB control efforts, note scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite potential safety concerns, Jazz Pharmaceuticals/UCB's sodium oxybate (JZP-6) will account for more than 15 percent of the fibromyalgia drug market in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Sodium oxybate has demonstrated robust efficacy in Phase III clinical trials for fibromyalgia and interviewed thought leaders are impressed with its effect on several key symptom domains of fibromyalgia, which include pain, sleep and fatigue.
Parents with allergies are more likely to pass them on to their same gender children than to children of the opposite gender, say researchers.
As a follow-up to the recent Salmonella outbreak linked to peanut butter, the U.S. Food and Drug Administration (FDA) is informing consumers that ConAgra has extended their recall of all Peter Pan peanut butter, and all Great Value peanut butter beginning with product code 2111, including peanut butter toppings, back to October 2004.
› Verified 3 days ago
Rania Wood, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 17472 Eastern Pines Ct, Canyon Country, CA 91387 Phone: 818-438-5444 Fax: 800-832-2321 |